Lana Zhovtis Ryerson, MD
Neurology · Neptune, NJNPI 1831344308
Payments from drug & device makers
Across 341 payments — averaging $3806.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$787K
- Novartis$220K
- Genentech, Inc.$140K
- TG Therapeutics, Inc.$50K
- Roche Products Limited$45K
- Bristol Myers Squibb$21K
- plus $36K from 14 others
Across 1 payment — averaging $424.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$424
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 67 | $786,552 |
| Novartis | 53 | $220,163 |
| Genentech, Inc. | 19 | $140,315 |
| TG Therapeutics, Inc. | 39 | $49,797 |
| Roche Products Limited | 26 | $44,565 |
| Bristol Myers Squibb | 11 | $20,591 |
| Genentech USA, Inc. | 29 | $12,343 |
| Hoffmann-la Roche Limited | 7 | $11,530 |
| Sanofi | 13 | $11,061 |
| Johnson & Johnson | 38 | $284 |
| Amgen(2 entities) | 10 | $179 |
| EMD Serono, Inc. | 5 | $173 |
| AstraZeneca | 9 | $161 |
| ANI Pharmaceuticals, Inc. | 4 | $65 |
| Vanda Pharmaceuticals Inc. | 4 | $63 |
| Acorda Therapeutics, Inc | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| UCB, Inc. | 1 | $16 |
| Banner Life Sciences, LLC | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
How this compares
$1,297,952 in reported general payments places this provider in the 95th percentile of 521 neurology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Neptune
- David DuncanNeptune$1.5M
- Mary Ann PiconeTeaneck$2.8M
- Steven BromleyAudubon$1.7M
- Amos KatzEatontown$1.2M
- Fiona GuptaOradell$1.1M
- Andrew SylvesterBridgewater$1.1M
- Machteld HillenNewark$999K
- Matthew TremblayLivingston$812K
- Noah GilsonWest Long Branch$800K
- Matthew DavisMiddletown$785K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.